Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of MMP inhibition with doxycycline in lower limb vascular restenosis
2004-004876-36Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in arteriosclerosis obliterans and restenosis comparing Doxycycline SDD with Placebo (2 arms). Primary endpoints: MMP activity comparison between SDD and placebo, C-reactive protein (CRP) levels and 2 more. Started Feb 2005; status: completed.
02
Drugs
doxycycline
03
Conditions
arteriosclerosis obliteransrestenosis
Beyond the preview
Go deeper on 2004-004876-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004876-36.